These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3699217)

  • 21. Etretinate in pustular psoriasis of palms and soles.
    White SI; Marks JM; Shuster S
    Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Skeletal changes caused by etretinate].
    Crespi HG; Massimo JA; Gentile F; Cordero AA
    Med Cutan Ibero Lat Am; 1986; 14(2):77-81. PubMed ID: 3528712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal changes after long-term therapy with synthetic retinoids.
    Herrmann G; Jungblut RM; Goerz G
    Br J Dermatol; 1997 Mar; 136(3):469-70. PubMed ID: 9115941
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertriglyceridemia in patients with psoriasis treated with cyclosporine.
    Grossman RM; Delaney RJ; Brinton EA; Carter DM; Gottlieb AB
    J Am Acad Dermatol; 1991 Oct; 25(4):648-51. PubMed ID: 1791223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Curling and kinking of hair caused by etretinate].
    Schauder S; Tsambaos D; Nikiforidis G
    Hautarzt; 1992 Aug; 43(8):509-13. PubMed ID: 1506218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of etretinate on the liver in psoriasis.
    Camuto P; Shupack J; Orbuch P; Tobias H; Sidhu G; Feiner H
    Am J Surg Pathol; 1987 Jan; 11(1):30-7. PubMed ID: 3789256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etretinate therapy for psoriasis and other keratinizing disorders: a 10-year retrospective study in Singapore.
    Shahidullah M; Tham SN; Goh CL
    Int J Dermatol; 1993 Sep; 32(9):686-9. PubMed ID: 7691773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse hepatic reactions associated with etretinate in patients with psoriasis--analysis of 22 cases.
    Thirumoorthy T; Shupack JL
    Ann Acad Med Singap; 1988 Oct; 17(4):477-81. PubMed ID: 3066276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ectropion: an adverse effect of etretinate therapy for psoriasis.
    Brenner S; Wolf R; Landau M
    DICP; 1990 Oct; 24(10):1007. PubMed ID: 2244393
    [No Abstract]   [Full Text] [Related]  

  • 33. Skeletal abnormalities and etretinate therapy.
    N Engl J Med; 1987 Apr; 316(18):1164-5. PubMed ID: 3574365
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C
    Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etretinate-induced skeletal muscle damage.
    Hodak E; David M; Gadoth N; Sandbank M
    Br J Dermatol; 1987 May; 116(5):623-6. PubMed ID: 2954577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral neuropathy during etretinate therapy for psoriasis.
    Hammer CJ; Carter CC; Hanifin JM
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):272-3. PubMed ID: 8381828
    [No Abstract]   [Full Text] [Related]  

  • 40. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.